Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A genetic condition that affects the eyes and skin. It is mainly found in females and is characterized by small or poorly developed eyes (microphthalmia) and characteristic linear skin markings on the head and neck. The signs and symptoms of this condition may include abnormalities of the brain, heart, and genitourinary system. Other symptoms may include short stature, developmental delay, and finger and toenails that do not grow normally (nail dystrophy). MLS syndrome is typically caused by either a deletion of certain genetic material on the p (short) arm of the X chromosome or by a mutation in the HCCS gene. In some cases, it may be caused by mutations in the COX7B and NDUFB11 genes, (also located on the X chromosome). According to the mutated gene, the disease may be classified in three subtypes. This condition is inherited in an X-linked manner and is thought to result in serious early developmental concerns in males, leading to almost no males with this condition surviving to delivery.Although there is no specific treatment or cure for MLS syndrome, there may be ways to manage the symptoms. A team of doctors is often needed to figure out the treatment options based on each person's symptoms.
No HPO annotations are available for this condition.
Microphthalmia with linear skin defects (MLS) syndrome is characterized by unilateral or bilateral microphthalmia or anophthalmia and/or jagged skin defects on the face and neck . MLS syndrome is usually lethal in males [, , , , , , , , , ]. Phenotypic variability. Inter- and intrafamilial phenotypic variability has been described. The manifestations differ among affected individuals and, although most display the classic phenotype of MLS syndrome, many have only a subset of characteristic features: some show the characteristic skin defects without ocular abnormalities, whereas others have eye abnormalities without skin defects . For example, a female with a normal phenotype except for typical MLS syndrome skin defects had an affected female fetus with anencephaly.
Eye finding...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Microphthalmia with linear skin defects (MLS) syndrome should be suspected in females with one or both major criteria especially in the presence of a family history consistent with X-linked inheritance with male lethality (see , , and ). Almost all individuals with MLS syndrome are female; however, a few affected males, typically with an XX karyotype, have been reported.
Major Criteria
Microphthalmia and/or anophthalmia
Reported in 81% of affected individuals
Can be unilateral or bilateral
Linear skin defects
Reported in 75% of affected individuals
Present at birth
Usually involve the face and neck , although the scalp and occasionally the upper trunk may be involved
Heal with age, leaving minimal residual scarring
The clinical signs observed in ML...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Table 2. Disorders to Consider in the Differential Diagnosis of MLS Syndrome
Disorder | Gene(s) | MOI | Clinical Features |
|---|---|---|---|
PORCN | XL | Distinctive skin findings (dermal hypoplasia); Ophthalmologic manifestations | — |
In focal dermal hypoplasia:limb skeletal malformations Incontinentia pigmenti (IP) | IKBKG(NEMO) | XL |
No approved treatments are currently available for linear skin defects with multiple congenital anomalies. The disease remains an area of unmet medical need.
To establish the extent of disease and needs in an individual diagnosed with microphthalmia with linear skin lesions (MLS) syndrome, the following evaluations (if not performed as part of the evaluation that led to the diagnosis) are recommended:
Ophthalmologic examination
Dermatologic evaluation for skin lesions
Brain MRI for corpus callosum dysgenesis and other neurologic abnormalities
Developmental assessment, with further evaluation if significant delays are identified
Cardiac evaluation
Hearing evaluation, as hearing loss is observed in 8% of cases
Consideration of abdominal MRI and standard protocols for management of diaphragmatic hernia
Consultation with a clinical geneticist and/or genetic counselor
The following are appropriate:
Under the guidance of an oculoplastics specialist, use of a prosthesis in severe microphthalmia and anophthalmia
Regular care by a dermatologist for individuals with significant skin lesions
Referral to a pediatric neurologist for evaluation and treatment if microcephaly, seizures, and/or other neurologic abnormalities are present
Appropriate developmental therapies and special education as indicated for developmental delay and intellectual disability
Standard care for cardiac concerns and other malformations, when present
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected indi...
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
View trials for linear skin defects with multiple congenital anomalies
Monitoring and follow up with ophthalmologist, dermatologist, pediatric neurologist, and other professionals as needed is appropriate. Affected individuals with cardiac concerns should have regular complete evaluation at intervals determined by the cardiologist.
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for linear skin defects with multiple congenital anomalies.
9 publications have been identified in PubMed for linear skin defects with multiple congenital anomalies. Research spans Case Report / Case Series (56%), Review / Meta-Analysis (11%), and Clinical Trial Publication (11%).
D'Alessio AM (2026). [PMID: 42014911](https://pubmed.ncbi.nlm.nih.gov/42014911/). *Eur J Hum Genet*. [Review / Meta-Analysis]
He Y (2025). [PMID: 40108654](https://pubmed.ncbi.nlm.nih.gov/40108654/). *Arthritis research & therapy*. [Basic Science / Preclinical]
Chen K (2025). [PMID: 40464756](https://pubmed.ncbi.nlm.nih.gov/40464756/). *The Journal of dermatological treatment*. [Case Report / Case Series]
Alassouli YM (2025). [PMID: 41426779](https://pubmed.ncbi.nlm.nih.gov/41426779/). *Cureus*. [Case Report / Case Series]
Tsuge T (2025). [PMID: 40452392](https://pubmed.ncbi.nlm.nih.gov/40452392/). *Pediatrics international : official journal of the Japan Pediatric Society*. [Case Report / Case Series]
Álvarez Vega DR (2025). [PMID: 40490108](https://pubmed.ncbi.nlm.nih.gov/40490108/). *Urology*. [Case Report / Case Series]
Zhang W (2025). [PMID: 39953436](https://pubmed.ncbi.nlm.nih.gov/39953436/). *The Journal of international medical research*. [Case Report / Case Series]
Elsanadi RA (2024). [PMID: 39004348](https://pubmed.ncbi.nlm.nih.gov/39004348/). *Journal of the American Academy of Dermatology*. [Epidemiology / Natural History]
Yoshikawa F (2024). [PMID: 38110600](https://pubmed.ncbi.nlm.nih.gov/38110600/). *Sleep & breathing = Schlaf & Atmung*. [Clinical Trial Publication]
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 4:05 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Skin lesions; Ocular abnormalities (present in 35% of those w/IP diagnosis)
Verrucous lesions Oculocerebro-cutaneous syndrome (OCCS)(OMIM 164180) | ? | ? | Focal skin defects; Anophthalmia / microphthalmia |
Aicardi syndrome | ? | XL | Microphthalmia; Pigmentary lesions of the skin |
Source: GeneReviews — "Microphthalmia with Linear Skin Defects Syndrome"